LifeScience
Docquity Launches Engage To Bring Ai Powered Market Intelligence To HCP Engagement Across Asia
Docquity, a leading health tech company in Asia, announced the launch of Docquity EngageTM, an AI&nb...
January 16, 2026 | News
Animate Biosciences Delivers Ai Designed Peptides That Match Standard Of Care In Pulmonary Fibrosis Model
Animate Biosciences announces positive preclinical results from a mouse model of pulmonary fibrosis demonstrating that two of its AI-designed therapeu...
January 15, 2026 | News
Novartis Secures Worldwide Licence To PepLib Peptide Asset To Expand Radioligand Therapy Pipeline
Zonsen PepLib Biotech Inc. announced that it has entered into a worldwide license agreement with Novartis for an undisclosed peptide-based asset in t...
January 15, 2026 | News
Australia TGA Clears NMN As A Permissible Therapeutic Ingredient In Landmark Longevity Move
One of the most popular ingredients in the field of longevity science globally, nicotinamide mononucleotide (NMN) has officially been listed as...
January 15, 2026 | News
Thermo Fisher And NVIDIA Join Forces To Build The AI Powered Laboratory Of The Future
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced a strategic collaboration with NVIDIA to power AI-based solutions...
January 13, 2026 | News
Clover Advances Global First In Class Respiratory Vaccine Strategy With Phase Two Launch
- Phase 2 Initiation Strengthens Global First-in-Class Potential for Clover's Protein-Based RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candid...
January 13, 2026 | News
Kainova Therapeutics Rebrands To Power The Next Wave Of GPCR Driven Clinical Growth
Kainova Therapeutics rebrand reflects expanding capabilities powering next stage of corporate growth Kainova champions scientific agility, bold ambition...
January 13, 2026 | News
China Approves ArkBio Aizhida For ADHD With Rapid Onset And All Day Symptom Control
Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that China's National Medical Products Administration (NMPA) has approved the...
January 12, 2026 | News
Zai Lab Secures China Approval For AUGTYRO In NTRK Fusion Positive Solid Tumours
-Zai Lab Limited announced that China’s National Medical Products Administration (NMPA) has approved the supplemental New Drug Application (sND...
January 09, 2026 | News
UP Oncolytics Wins $75,000 Illinois Innovation Voucher To Advance Breakthrough Glioblastoma Therapy
UP Oncolytics, a biotech company in Rosalind Franklin University's Helix 51 biomedical incubator, was awarded an Illinois Innovation Voucher gran...
January 09, 2026 | News
ASGCT And Orphan Therapeutics Accelerator Launch CGTxchange To Revive Stalled Cell And Gene Therapies
First-of-its-kind venture to facilitate and catalyze development of deprioritized cell and gene therapies, supported by AI-enabled platform The American S...
January 09, 2026 | News
Title21 Acquires MyCellHub To Strengthen Digital Manufacturing And Quality Leadership
Strategic acquisition accelerates Title21’s mission to deliver comprehensive, compliant, and integrated digital solutions for regulated healthcare an...
January 08, 2026 | News
Nuclera Secures First Commercial Sales In Asia With Landmark Installations In Taiwan
Installations at National Taiwan University and National Cheng Kung University expand Nuclera’s global footprint with first commercial sales in Asi...
January 08, 2026 | News
Sichuan Kelun Biotech Secures NMPA IND Approval For SKB105 Antibody Drug Conjugate In Advanced Solid Tumours
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that its Investigational New Drug (IND) appli...
January 07, 2026 | News
Most Read
- Can APAC Biomanufacturing Decarbonise Without Pricing Itself Out?
- The Algorithm on the GMP Floor: AI Promises a Smarter Plant. Regulators Demand the Audit Trail.
- APAC's Peptide-Capacity Gamble
- After the Rush: APAC's mRNA and Vaccine Capacity Hangover
- The Biosimilar Race: Factory to the World — or Stuck in the Copycat Economy?
- The Vein-to-Vein Problem: Can APAC's Cold Chain Carry Advanced Therapies?
- Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck
- Can APAC Build Radioligand Therapy Before the Atoms Decay?
- The Great Biopharma Reset: 50 Developments That Changed Everything in H1 2026
- Beyond the Trial: Can Real-World Evidence Earn Regulatory Trust in APAC?
- Beyond the Obvious Giant: Where APAC's Clinical Trials Go Next
- The Frontier That Won’t Quite Arrive
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
